Valeant CEO Pearson Hospitalized for Case of ‘Severe’ Pneumonia
- Company isn't giving details about nature of his illness
- Investors have sent stock down 57% from high amid scandals
This article is for subscribers only.
Valeant Pharmaceuticals International Inc., the drugmaker battered by scandals and questions about sales, said its chief executive officer spent Christmas in a hospital being treated for “severe” pneumonia.
J. Michael Pearson, 56, was admitted recently and is receiving treatment, company spokeswoman Laurie Little said Friday by e-mail. She declined to elaborate.